The implementation of the Oncology Care Model has brought profound culture changes to how oncologists take care of patients and how they operate practices, explained Lucio Gordan, MD, of Florida Cancer Specialists.
The implementation of the Oncology Care Model has brought profound culture changes to how oncologists take care of practices and how they operate practices, explained Lucio Gordan, MD, of Florida Cancer Specialists.
Transcript (slightly modified)
How do practices and payers work together to implement OCM?
OCM has brought a very profound change to oncology practice in the country. One hundred ninety practices are participating in OCM these days, and we have to go through culture changes as to how we take care of patients, operational changes, revenue cycle changes, communication changes as to how the operating team communicates with the providers, the physicians, nurse practitioners, etc. It has certainly been a very profound, interesting, rewarding, and with many challenges ahead still, experience for all of us at Florida Cancer Specialists. So, how we did it. Obviously, there was a process of educating the staff, educating the physicians. We are a large practice in Florida. We have about 100+ offices, almost 400 providers, so we had to do webinars to discuss oncology care model, we got physicians involved via e-mail, Q&A, all those things to make it happen. So, it was a very laborious process that continues to be active and we perfect every time.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More